Insider Trading & Ownership - Liau Gene

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Liau Gene
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-12-28
Sale
2021-03-04
5:00 pm
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
5,344$62.93$336,297233,094
(Direct)
View
2020-10-16
Sale
2020-10-20
4:52 pm
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
37,851$38.16$1,444,206306,521
(Direct)
View
2020-10-13
Sale
2020-10-13
5:43 pm
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
1,649$40$65,960145,917
(Direct)
View
2020-06-01
Sale
2020-06-03
4:57 pm
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
20,000$26.35$527,03785,389
(Direct)
View
2020-05-22
Sale
2020-05-26
5:58 pm
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
7,500$30$225,000147,566
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-12-28
Exercise
2021-03-04
5:00 pm
N/A
N/A
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
13,195$0.6233,094
(Direct)
View
2020-12-28
Exercise
2021-03-04
5:00 pm
N/A
2028-04-02
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
13,195$0233,094
(Direct)
View
2021-03-02
Option Award
2021-03-04
5:00 pm
N/A
2031-03-01
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
40,800$0233,094
(Direct)
View
2020-10-16
Exercise
2020-10-20
4:52 pm
N/A
N/A
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
36,348$0.6306,521
(Direct)
View
2020-10-16
Exercise
2020-10-20
4:52 pm
N/A
2028-04-02
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
37,851$0306,521
(Direct)
View
2020-10-19
Exercise
2020-10-20
4:52 pm
N/A
N/A
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
1,503$2.19306,521
(Direct)
View
2020-10-13
Exercise
2020-10-13
5:43 pm
N/A
N/A
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
1,649$0.6145,917
(Direct)
View
2020-10-13
Exercise
2020-10-13
5:43 pm
N/A
2028-04-02
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
1,649$0145,917
(Direct)
View
2020-06-01
Exercise
2020-06-03
4:57 pm
N/A
2028-12-12
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
20,000$085,389
(Direct)
View
2020-06-01
Exercise
2020-06-03
4:57 pm
N/A
N/A
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
20,000$2.1985,389
(Direct)
View
2020-05-22
Exercise
2020-05-26
5:58 pm
N/A
N/A
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
7,500$0.6147,566
(Direct)
View
2020-05-22
Exercise
2020-05-26
5:58 pm
N/A
2028-04-02
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
7,500$0147,566
(Direct)
View
2019-12-20
Exercise(A)
2020-05-26
5:57 pm
N/A
2028-04-02
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
13,500$0290,632
(Direct)
View
2019-12-20
Exercise
2020-04-15
7:33 pm
N/A
N/A
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
13,500$0.6304,132
(Direct)
View
2019-12-20
Exercise
2020-04-15
7:33 pm
N/A
2028-04-02
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
13,500$0304,132
(Direct)
View
2020-03-25
Option Award
2020-03-26
6:04 pm
N/A
2030-03-24
Stoke Therapeutics Inc.STOKLiau Gene
EVP Research & Preclinical Dev
42,000$042,000
(Direct)
View
(A) Indicate amendment filing.